Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Müllerian tumours

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Pathology

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-9896(199712)183:4<424::AID-PATH949>3.0.CO;2-LPMID 9496259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

  1996cited by this paper
• Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns.

  1995cited by this paper
• p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.

  1995cited by this paper
• Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis.

  1995cited by this paper
• Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.

  1995cited by this paper
• p53 gene mutation in female genital tract carcinosarcomas (malignant mixed müllerian tumors): a clinicopathologic study of 74 cases.

  1994cited by this paper
• p53 immunostaining suggests that uterine carcinosarcomas are monoclonal

  1994cited by this paper
• Detection of the t(14,18) Translocation in Frozen and Formalin‐fixed Tissue

  1993cited by this paper
• Characteristics of cloned cells of mixed müllerian tumor of the human uterus carcinoma cells showing myogenic differentiation in vitro

  1993cited by this paper
• Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases.

  1993cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

  1992cited by this paper
• Fidelity mechanisms in DNA replication.

  1991cited by this paper
• Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation.

  1991cited by this paper
• 'Touchdown' PCR to circumvent spurious priming during gene amplification.

  1991cited by this paper
• Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma.

  1991cited by this paper
• Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

  1991cited by this paper
• Mixed müllerian tumours of the uterus--prognostic factors: a clinical and histopathologic study of 147 cases.

  1990cited by this paper
• The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the Uterus: A Clinicopathologic and Immunohistochemical Study

  1990cited by this paper
• Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases.

  1990cited by this paper
• Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

  1989cited by this paper
• Analysis of tumor heterogeneity in a patient with synchronously occurring female genital tract malignancies by DNA flow cytometry, dna fingerprinting, and immunohistochemistry

  1988cited by this paper
• Spindle-Cell Carcinoma of the Aerodigestive Tract: An Immunohistochemical Analysis of 21 Cases

  1987cited by this paper
• Metaplastic Carcinoma of the Breast : A Clinicopathologic Study of 29 Patients

  1987cited by this paper
• Epithelial antigens in malignant mixed Müllerian tumours of endometrium

  1986cited by this paper
• Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus.

  1963cited by this paper
• MIXED MESODERMAL TUMOURS OF THE UTERUS

  1955cited by this paper

• High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma

  2026cites this paper
• Genomics of ovarian cancers and the potential of precision medicine

  2025cites this paper
• Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes

  2024cites this paper
• Recent Advances in the Classification of Gynecological Tract Tumors.

  2023cites this paper
• Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature

  2022cites this paper
• Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin

  2022cites this paper
• State of the science: Uterine carcinosarcomas: From pathology to practice.

  2021cites this paper
• Uterine carcinosarcoma: an overview.

  2021cites this paper
• Endometrial Cancer.

  2020cites this paper
• Endometrial Glandular Neoplasia

  2020cites this paper
• Clinical profile and treatment outcome of collision carcinoma in cervix

  2020cites this paper
• Ovarian carcinosarcoma genomics and pre-clinical models highlight the N-MYC pathway as a key driver and susceptibility to EMT-targeting therapy

  2020cites this paper
• Genomics of gynaecological carcinosarcomas and future treatment options.

  2020cites this paper
• Clinical actionability of molecular targets in endometrial cancer

  2019cites this paper
• ♀Ovarian Mixed Epithelial–Stromal Tumors

  2019cites this paper
• Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma

  2019cites this paper
• Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma

  2019cites this paper
• Mutational and Immunophenotypic Profiling of a Series of 8 Tubo-ovarian Carcinosarcomas Revealed a Monoclonal Origin of the Disease

  2019cites this paper
• Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition

  2019cites this paper
• Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma

  2019cites this paper
• Carcinosarcoma of the Pancreas: A Rare Type of Pancreatic Neoplasia

  2019cites this paper
• The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas

  2018cites this paper
• Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers?

  2018cites this paper
• Computational insights into the generation of chromosomal copy number changes

  2018cites this paper
• Caracterización molecular de los carcinosarcomas de endometrio.

  2018cites this paper
• Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.

  2018cites this paper
• Molecular Pathology of Uterine Carcinosarcoma

  2017cites this paper
• Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma

  2017cites this paper
• Pancreatic carcinosarcoma mimics malignant intraductal papillary mucinous neoplasm

  2017cites this paper
• Integrated Molecular Characterization of Uterine Carcinosarcoma.

  2017cites this paper
• miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas

  2017cites this paper
• Loss of CDKN2A Promoter Methylation Coincides With the Epigenetic Transdifferentiation of Uterine Myosarcomatous Cells

  2016cites this paper
• Landscaper seeks remunerative position

  2016cites this paper
• The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

  2016cites this paper
• Carcinosarcoma of the Lesser Omentum

  2016cites this paper
• Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors.

  2016cites this paper
• Extragenital malignant mixed Mullerian tumor in the incisional hernia - primary carcinosarcoma in the abdominal wall: case report.

  2015cites this paper
• A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.

  2015cites this paper
• Rare uterine cancer: carcinosarcomas. Review from histology to treatment.

  2015cites this paper
• Carcinosarcoma of the Pancreas: How a Common Blood Disorder Can Hide an Extremely Rare Tumour

  2015cites this paper
• Role of p53 Pathway Alterations in Uterine Carcinosarcomas (Malignant Mixed Müllerian Tumors)

  2014cites this paper
• PAX8 Expression in Uterine Malignant Mesodermal Mixed Tumor (Carcinosarcoma)

  2014cites this paper
• Heterologous type of malignant mixed Müllerian tumor of the uterus presenting as a vulvar mass.

  2014cites this paper
• A new grading system “two-tier” in clasification of ovarian serous carcinoma and evaluation of P53 gene expression by immunohistochemical staining

  2014cites this paper
• Pancreatic carcinosarcoma: case report of a rare type of pancreatic neoplasia.

  2013cites this paper
• p53 unterdrückt die Bildung von Typ-II-Endometriumkarzinomen im Mausmodell und ist ein unabhängiger negativer Prognosefaktor bei Patientinnen mit Endometriumkarzinom

  2013influential citation
• Endometrial carcinoma: a step closer to individualized therapy? Exploring transcriptional alterations in relation to prognostic biomarkers

  2013cites this paper
• Establishment of Primary Xenograft Model From Newly Characterized Patient Extrauterine Carcinosarcoma

  2013cites this paper
• p53 is not related to Ki-67 immunostaining in the epithelial and mesenchymal components of female genital tract carcinosarcomas.

  2013cites this paper
• Molecular Pathology of Ovarian Cancer

  2013cites this paper
• Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: clinicoimmunohistochemical and histogenetic characteristics.

  2012cites this paper
• Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma.

  2012cites this paper
• Pancreatic carcinosarcoma in a cat.

  2012cites this paper
• Expression profiles of carcinosarcoma of the uterine corpus—are these similar to carcinoma or sarcoma?

  2012cites this paper
• p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans

  2012cites this paper
• Use of mutation profiles to refine the classification of endometrial carcinomas

  2012cites this paper
• Best Practice & Research Clinical Obstetrics and Gynaecology

  2011cites this paper
• Development of an ovarian cancer screening decision model that incorporates disease heterogeneity

  2011cites this paper
• Staging of uterine sarcomas.

  2011cites this paper
• Incidence and Survival Trends of Uncommon Corpus Uteri Malignancies in the Netherlands, 1989–2008

  2011cites this paper
• Carcinosarcoma of the pancreas: a unique case with emphasis on metaplastic transformation and the presence of undifferentiated pleomorphic high-grade sarcoma.

  2011cites this paper
• Tissue-specific signatures of activating PIK3CA and RAS mutations in carcinosarcomas of gynecologic origin.

  2011cites this paper
• Malignant mixed mullerian tumor in two patients receiving tamoxifen therapy

  2011cites this paper
• Modern Soft Tissue Pathology: STROMAL TUMORS AND TUMOR-LIKE LESIONS OF THE FEMALE GENITAL TRACT

  2010cites this paper
• The Female Genital Tract

  2010cites this paper
• Ovarian Malignant Mixed Mesodermal Tumor With Neuroectodermal Differentiation: A Multifaceted Evaluation

  2010cites this paper
• Pathologic and molecular features of uterine carcinosarcomas.

  2010cites this paper
• Invasive ductal breast cancer within a malignant phyllodes tumor: case report and assessment of clonality.

  2010cites this paper
• Coexistence of a Clear Cell Adenocarcinoma and an Adenosarcoma With a Heterologous Rhabdomyosarcoma in an Endometriotic Cyst of the Ovary: A Case Study

  2009cites this paper
• Sarcomes utérins après exposition au tamoxifène dans les suites d ’ un cancer du sein : mise au point sur l ’ étiopathogénie Uterine sarcoma associated with tamoxifen use after breast cancer : Review of the pathogenesis

  2009cites this paper
• Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma.

  2009cites this paper
• CHAPTER 37 – Uterus

  2009cites this paper
• Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.

  2009cites this paper
• Ascitic fluid cytology of a malignant mixed müllerian tumor of the peritoneum: A report of two cases with special reference to p53 status

  2009cites this paper
• Ovarian endometrioid, clear cell, Brenner, and rare epithelial–stromal tumors

  2009cites this paper
• Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas

  2009cites this paper
• [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis].

  2009cites this paper
• Molecular genetic aberrations of ovarian and uterine carcinosarcomas—a CGH and FISH study

  2008influential citation
• Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical Implications

  2008cites this paper
• Endometrioid endometrial adenocarcinoma recurring as carcinosarcoma

  2008cites this paper
• Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.

  2008cites this paper
• Hormonal heterogeneity of endometrial cancer.

  2008cites this paper
• Complementary techniques: laser capture microdissection--increasing specificity of gene expression profiling of cancer specimens.

  2007cites this paper
• Ovarian Serous Carcinogenesis—A Proposed Model

  2007cites this paper
• [Carcinosarcoma of the ovary].

  2007cites this paper
• Le carcinosarcome ovarien

  2007cites this paper
• DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis

  2006cites this paper
• Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum.

  2005cites this paper
• Microarray Analysis of Endometrial Carcinomas and Mixed Mullerian Tumors Reveals Distinct Gene Expression Profiles Associated with Different Histologic Types of Uterine Cancer

  2005cites this paper
• Divergent Differentiation In Malignant Soft Tissue Neoplasms: The Paradigm of Liposarcoma and Malignant Peripheral Nerve Sheath Tumor

  2005cites this paper
• A Review and Update of Morphologically Bland Vulvovaginal Mesenchymal Lesions

  2005cites this paper
• Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases.

  2005cites this paper
• Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature

  2005cites this paper
• Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis: A Mutational Analysis With Immunohistochemical Correlation

  2005cites this paper
• Primary bone carcinosarcoma: Chondrosarcoma and squamous cell carcinoma with keratin pearl formation

  2005cites this paper
• Epithelial-Mesenchymal Transitions in Human Cancer

  2005cites this paper
• Role of cyclin-dependent kinase p27 in uterine carcinosarcomas

  2004cites this paper
• Carcinosarcoma of the ovary

  2004cites this paper
• Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

  2004cites this paper
• Low-Grade Trichoblastic Carcinosarcoma of the Skin

  2004cites this paper